依赖的抗生素:结构-活性关系及其脂质标的确定
Jeremy Goodyear1, Matthew Diamandas2, Ryan Moreira3
1Department of Chemistry, University of Waterloo, 200 University Ave. West, Waterloo, Ontario N2L3G1, Canada.
ACS infectious diseases
|December 24, 2024
概括
取决于的抗生素 (CDA) 是循环性脂抗生素. 研究人员合成了CDA4b类似物,以探索结构-活性关系,并将心脏脂蛋白确定为主要的脂质标.
科学领域:
- 微生物学 微生物学
- 药用化学 医学化学
- 生物化学 生物化学
背景情况:
- 依赖性抗生素 (CDA) 是20世纪80年代发现的膜活性循环脂抗生素 (cLPA).
- 它们的精确分子标和作用机制在很大程度上仍未被阐明.
研究的目的:
- 为CDA4b及其类似物开发新的合成路径.
- 关于脂质尾部和特定氨基酸残留物的结构-活性关系 (SAR) 的研究 (第3,第9和第11位).
- 为了确定CDAs的主要脂质标.
主要方法:
- 化学合成CDA4b类似物,对脂质尾部和氨基酸残留物进行修改.
- 最低抑制度 (MIC) 测定具有和没有外源性脂.
- 使用模型膜和CDA类似物进行光光谱学.
主要成果:
- 一种CDA4b的环类型显示出活性增加,这表明环氧化物对共价结合不必.
- 脂质尾部延长到10个碳元素,增强了环烯类似物的活性.
- 在位置9的修改表明了胺部分的重要性,但不是基组.
- 在位置11用l-kynurenine (l-Kyn) 取代l-Trp的影响很小,而在位置3用d-Kyn取代d-Trp则显著降低了活性.
- 卡迪奥利平被确定为CDAs的主要脂质标.
结论:
- 可以用修改的结构合成CDA4b类似物来探测SAR.
- 卡迪奥利平是CDA的唯一主要脂质标,使其与其他依赖的抗生素区别开来.
- 了解CDA-心脏蛋白相互作用可以为新抗生素的开发提供信息.
相关概念视频
Structure-Activity Relationships and Drug Design
510
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
510
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
516
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
516
Antihypertensive Drugs: Action of Calcium Channel Blockers
455
Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
455
Biosynthesis of Lipids
Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
79
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
79


